This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Harlan Laboratories Taps Industry Veteran Dr. Philip Damiani To Lead Contract Breeding Services

INDIANAPOLIS, April 11, 2013 /PRNewswire/ -- Harlan Laboratories, a leading contract research organization and research models and services company, today announced that well known industry veteran Philip Damiani, Ph.D. has joined the company as Head of Global Embryological Sciences and Transgenic Support.

Dr. Damiani brings both the scientific expertise and hands-on client experience needed as Harlan continues its strategic global growth. In his new role, Dr. Damiani will oversee the company's global contract breeding services, which include rederivation, cryopreservation, revitalization, colony management, contract breeding and quarantine services.   

For more than 15 years, Dr. Damiani has worked extensively in the field of assisted reproductive technology, including sperm and embryo cryopreservation,  in vitro fertilization and nuclear transfer (cloning) for a wide variety of species. He is considered an expert in the areas of transgenic breeding, embryological cryopreservation and also owns several patents for cloning methods, including domestic and non-domestic species.  

"Philip is an ideal leader for our newly expanded contract breeding services given his extensive knowledge in assisted reproductive technology and experience managing a global team of research scientists," said Doug Vaughan, President, Research Models and Services at Harlan Laboratories. "His leadership acumen and track record of success working with research scientists in leading pharmaceutical and academic centers aligns perfectly with our corporate commitment of being the most dependable supplier of contract breeding services in the industry."

Previously, Dr. Damiani served as Head of Global Embryology for Taconic, where he was responsible for coordinating scientific research and development within the company's embryology laboratories. Prior to his time at Taconic, Dr. Damiani held progressive leadership roles at Genetic Savings and Clone, Inc., Advanced Cell Technology and Infigen, Inc.

Dr. Damiani received his B.S. in Zoology from the State University of New York at Oswego in 1988 and his doctorate from the University of Massachusetts in Reproductive Physiology in 1998.

For more information, visit www.harlan.com.

About Harlan Laboratories, Inc. Harlan Laboratories, Inc. is a leading provider of essential, pre-clinical and non-clinical contract research, research models, animal diets, and services to the pharmaceutical, biotech, medical device, agrochemical and chemical industries, as well as universities, government, and other research organizations. Our focus is on providing customers with products and services to optimize the discovery and safety of new medicines and compounds.

CONTACT: Michael Clark Miller Brooks, Inc. 317.873.8100 michael@millerbrooks.com

SOURCE Harlan Laboratories, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs